Vectors and methods for high throughput co-expressions

Details Vectors and methods for high throughput co-expressions Vectors and methods for high throughput co-expressions

2011-08-30

2011-08-30

Bowman, Amy (Department: 1635)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

C435S091100, C435S091310, C435S455000, C435S462000, C435S320100, C435S252300, C536S023100, C536S023700, C536S024500

Reexamination Certificate

active

08008016

ABSTRACT:
The present invention includes vectors and methods for high throughput co-expression.

REFERENCES:
patent: 4952496 (1990-08-01), Studier et al.
patent: 5021344 (1991-06-01), Armau et al.
patent: 5118620 (1992-06-01), Armau et al.
patent: 5284933 (1994-02-01), Döbeli et al.
patent: 5310663 (1994-05-01), Döbeli et al.
patent: 5693489 (1997-12-01), Studier et al.
patent: 5869320 (1999-02-01), Studier et al.
patent: 5888732 (1999-03-01), Hartley et al.
patent: 6143557 (2000-11-01), Hartley et al.
patent: 6171861 (2001-01-01), Hartley et al.
patent: 6270969 (2001-08-01), Hartley et al.
patent: 6277608 (2001-08-01), Hartley et al.
patent: 6720140 (2004-04-01), Hartley et al.
patent: 2005/0069929 (2005-03-01), Chestnut et al.
patent: 2006/0183193 (2006-08-01), Horanyi et al.
patent: 2007/0196838 (2007-08-01), Chestnut et al.
patent: 282042 (1988-09-01), None
Adams et al., “The Southeast Collaboratory for Structural Genomics: A High-Throughput Gene to Structure Factor,” 2003Acc. Chem. Res.36:191-198.
Ambion, the RNA Company. “RNA Interference and Gene Silencing—History and Overview,” Available online [retrieved on Jan. 6, 2006]. Retrieved from the Internet: <http://www.ambion.com/techlib/hottopics/rnai/rnai—may2002—print.html>; 8 pages.
Apfeld et al., “Cell Nonautonomy ofC. elegansdaf-2 Function in the Regulation of Diapause and Life Span,” 1998Cell95:199-210.
Ausubel et al., eds,Current Protocols in Molecular Biology, Green Publishing Assoc., Inc., John Wiley & Sons, Inc., NY 1994 (12 pages).
Bass, B., “The Short Answer,” 2001Nature411:428-429.
Benakis. “Artemisin and derivatives: recent progress in malaria treatment,” Indian Medlars Centre. Laboratory of Drug Metabolism, Dept. of Pharm., Univ. Medical Centre, Geneva, Switzerland. Journal of Parasitic Diseases. 1996. 10(1):65. Available online [retrieved on Mar. 9, 2006]. Retrieved from the Internet: <http://medind.nic.in/imvw/imvw13236.html>; 1 page.
Bernard et al., “The F plasmid CcdB protein induces efficient ATP-dependent DNA cleavage by gyrase,” 1993J. Mol. Biol. 234:534-541.
Bernard et al., “The 41 Carboxy-terminal Residues of the Mini-F Plasmid CcdA Protein are sufficient to Antagonize the Killer Activity of the CcdB protein,” 1991Mol. Gen. Genet. 226:297-304.
Brenner, “Target Selection for Structural Genomics,” 2000Nat. Struct. Biol. 7 Suppl:967-969.
Brenner et al., “Expectations from Structural Genomics,” 2000Protein Sci. 9:197-200.
Burley, “An Overview of Structural Genomics,” 2000Nat .Struct. Biol. 7 Suppl:932-934.
Campbell et al., “A monomeric red fluorescent protein,” 2002Proc. Natl. Acad. Sci. USA, 99:7877-7882.
Celestino et al., “Update of microbial genome programs for bacteria and archaea,” 2004.Gen Mol.Res. 3:421-431.
Chance et al., “Structural genomics: A pipeline for providing structures for the biologist,” 2002Protein Science11:723-738.
Chayen, “Protein crystallization for genomics: throughput versus output,” 2003J. Struct. Funct. Genomics4:115-120.
Cherry et al., “Genetic and physical maps ofSaccharomyces cerevisiae,” 1997Nature387(6632 Suppl):67-73.
Christendat et al., “Structural proteomics of an archaeon,” 2000Nat. Struct. Biol.7:903-909.
CLONTECH. Innovative Tools to Accelerate Discovery. Living Colors® User Manual. PT2040-1 (PR1Y691). Published Nov. 26, 2001. 47 pages.
Collins et al., “A Vision for the Future of Genomics Research, A blueprint for the genomic era,” 2003Nature422:835-847.
Cormack et al., “FACS—optimized mutants of the green fluorescent protein (GFP),” 1996Gene173:33-38.
Crabtree et al., “Facile and Gentle Method for Quantitative Lysis ofEscherichia coliandSalmonella typhimurium,” 1984J. Bact. 158:354-356.
Cuff et al., “Jpred: a consensus secondary structure prediction server,” 1998Bioinformatics Applications Note14:892-893.
Dolinski et al., “Changing perspectives in yeast research nearly a decade after the genome sequence,” 2005Genome Research15(12):1611-1619.
Drocourt et al., “Cassettes of theStreptoalloteichus hindustanusble gene for transformation of lower and higher eukaryotes to phleomycin resistance,” 1990Nucleic Acids Res. 18:4009.
Elshorst et al., “NMR solution structure of a complex of calmodulin with a binding peptide of the Ca2+ pump,” 1999Biochemistry38(38):12320-12332.
Facts on Acts. Artemisinin-Based Combination Therapies. Jan. 2006 Update. World Health Organization. 4 pages.
Falconer et al., “Chemical Treatment ofEscherichia coli: 1. Extraction of Intracellular Protein from Uninduced Cells,” 1997Biotechnol. Bioengin. 53:453-458.
Ferreira et al., “Distribution of Artemisinin inArtemisia annua,” 1996. Distribution of artemisinin in Artemisia annua. p. 579-584. J. Janick (ed.), Progress in New Crops. ASHS Press, Arlington, VA. Available online [retrieved on Mar. 9, 2006]. Retrieved from the Internet: <http://www.hort.purdue.edu
ewcrop/proceedings1996/v3-578.html>; 12 pages.
Fire et al., “Potent and specific genetic interference by double-stranded RNA inCaenorhabditis elegans,” 1998Nature391:806-811.
Gateway Technology Manual, Version E, updated Sep. 22, 2003; available on the wordwide web at invitrogen.com/content/sfs/manuals/gatewayman.pdf.
Gonczy et al., “Functional genomic analysis of cell division inC. elegansusing RNAi of genes on chromosome III,” 2000Nature408(6810):331-336.
Hartley et al., “DNA Cloning Using In Vitro Site-Specific Recombination,” 2000Genome Res. 10:1788-1795.
Henricksen et al., “Recombinant Replication Protein A: Expression, Complex Formation, and Functional Characterization,” 1994J. Biol. Chem. 269:11121-11132.
Invitrogen life technologies. Letter to Global Life Science Research Community. Re: “Gateway® Clone Distribution Policy,” Oct. 29, 2003. 4 pages.
Invitrogen life technologies. “Champion™ pET104 BioEase™ Gateway® Expression System, for Cloning and Expression of biotinylated fusion proteins inE. coli,” Catalog No. K104-01, Version C, Mar. 15, 2004, 25-0472. 36 pages.
Invitrogen Catalog # 11828-029. “Gateway® Vector Conversion System with One Shot® ccdB Survival™ Competent Cells,” Accessible at www.invitrogen.com/content/sfs/manuals/gatewayvectorconversion—ccdbsurvival—man.pdf Invitrogen Life Technologies Instruction Manual. Version A. Jun. 14, 2004.
Kamath et al., “Genome-wide RNAi screening inCarnorhabditis elegans,” 2003Methods30:313-321.
Kessler et al., “Study of Calmodulin Binding to the Alternatively Spliced C-Terminal Domain of the Plasma Membrane Ca2+Pump,” 1992Biochemistry31:11785-11792.
Landy, “Dynamic, Structural, and Regulatory Aspects of λ Site-Specific Recombination,” 1989Ann. Rev. Biochem. 58:913-949.
Lesley et al., “Structural genomics of theThermotoga maritimaproteome implemented in a high-throughput structure determination pipeline,” 2002Proc. Natl. Acad. Sci. USA99:11664-11669.
Li et al., “Coexpression of nuclear receptor partners increses their solubility and biological activities,” 1997Proc Natl Acad Sci, USA 94:2278-2283.
Lindblad-Toh et al., “Genome sequence, comparative analysis and haplotype structure of the domestic dog,” 2005Nature438:803-819.
Liu et al., “The high-throughput protein-to-structure pipeline at SECSG,” 2005Acta Cryst. 61:679-684.
Machalek, “From Genes to Proteins: NIGMS Catalogs the Shapes of Life,”NIH Record, Feb. 2001. Retrieved from the wordlwide web at nigms.nih.gov/psi/ and resb.org/pdb/strucgen.html#Wordwide.
Matz et al., “Fluroescent proteins from nonbioluminescent Anthozoa species,” 1999Nat. Biotechnol. 1

Affiliated with

Also associated with

Rating

Vectors and methods for high throughput co-expressions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Vectors and methods for high throughput co-expressions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vectors and methods for high throughput co-expressions will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2789733